Unicycive Therapeutics Cash Flow Statement 2019-2024 | UNCY

Fifteen years of historical annual cash flow statements for Unicycive Therapeutics (UNCY).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-30.54$-18.06$-10.02$-2.26$-2.17
$0.28$0.16$0.50$0.19$0.10
$12.07$1.07$3.85$0.79$0.59
$12.35$1.23$4.36$0.97$0.68
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$-1.37$-0.09$-1.35$-0.10$0.00
$-0.09$1.18$-0.11$-0.17$0.31
$-18.28$-15.65$-5.77$-1.46$-1.18
$-0.01$0.00$-0.03$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$-0.01$0.00$-0.03$0$0
$-0.50$-0.48$-0.02$1.42$0
$0$0$0$0$0
$-0.50$-0.48$-0.02$1.42$0
$0$0.01$22.39$0.14$1.17
$30.19$0.01$22.39$0.14$1.17
$0$0$0$0$0
$-2.15$0$0$-0.12$0
$27.54$-0.47$22.38$1.44$1.17
$9.25$-16.12$16.58$-0.02$-0.01
$1.77$1.05$0.97$0.23$0.02
$0$0$0$0$0